STOCKS TELEGRAPH

Tag: CLRO

  • 3 Stocks to Consider in the Market: Versus Systems (VS), ClearOne (CLRO), Hillcrest Energy Technologies (HLRTF)

    3 Stocks to Consider in the Market: Versus Systems (VS), ClearOne (CLRO), Hillcrest Energy Technologies (HLRTF)

    Recent activity in small-cap equities suggests a period of instability, marked by uneven performance. Price action and indicator signals reveal competing forces at play. Analyzing structural levels and trading volume can help interpret these trends. This perspective enhances decision-making under uncertainty.

    Versus Systems Inc (VS)

    Versus Systems Inc (NASDAQ: VS)’s stock price has plunge by 0.94%relation to previous closing price of $1.06. Nevertheless, the company has seen a -6.14% plunge in its stock price over the last five trading sessions. The volatility ratio for the week is 5.02%, and the volatility levels for the past 30 days are at 7.24% for VS. The simple moving average for the past 20 days is -4.92% for VS’s stock, with a -35.46% simple moving average for the past 200 days.

    VS Trading at 3.27% from the 50-Day Moving Average

    After a stumble in the market that brought VS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.19% of loss for the given period. Volatility was left at 7.24%, however, over the last 30 days, the volatility rate increased by 5.02%.

    ClearOne Inc (CLRO)

    ClearOne Inc (NASDAQ: CLRO) has experienced a decline in its stock price by -12.26% compared to its previous closing price of $3.1. However, the company has seen a fall of -17.58% in its stock price over the last five trading days, with a -38.29% drop in the past month and a -50.90% drop in the past quarter. The volatility ratio for the week is 8.27%, and the volatility levels for the past 30 days are 7.81% for CLRO. The simple moving average for the past 20 days is -27.31% for CLRO’s stock, with a -50.30% simple moving average for the past 200 days.

    CLRO Trading at -44.66% from the 50-Day Moving Average

    After a stumble in the market that brought CLRO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.36% of loss for the given period. Volatility was left at 7.81%, however, over the last 30 days, the volatility rate increased by 8.27%.

    Hillcrest Energy Technologies Ltd. (HLRTF)

    Hillcrest Energy Technologies Ltd. (HLRTF) continues to build its long-term narrative around its advanced power conversion technologies. While short-term trading remains muted, the company’s innovation pipeline is the primary focus. Investors are closely watching its progress toward commercialization.

    Market Momentum

    On April 14, the stock closed at $0.1010, down 1.17%, with very low volume of 1,000 shares compared to the 144,162 average. The market cap stands at $10.132M, with beta of -0.28 and EPS (TTM) of -0.0600. The stock remains within its 52-week range.

    Strategic Positioning

    Hillcrest is working to transition from development to real-world validation of its technologies. This includes preparing for demonstrations and engaging with partners. These steps are critical for future growth.

    Product Focus

    The PCS1000 Grid Power Conversion System is designed to deliver over 99% efficiency while reducing electromagnetic interference. Its scalable architecture supports applications up to 1.2 MW. It targets energy storage, microgrids, and data centers.

    Sector Outlook

    Demand for high-efficiency power systems continues to rise globally. Companies that can deliver measurable improvements are well-positioned. Hillcrest’s technology aligns with this demand.

  • 3 Stocks Making Big Moves: Wallbox (WBX), ClearOne (CLRO), Hillcrest Energy Technologies (HLRTF)

    3 Stocks Making Big Moves: Wallbox (WBX), ClearOne (CLRO), Hillcrest Energy Technologies (HLRTF)

    Ongoing developments in the small-cap space highlight a period marked by instability and rapid shifts in sentiment. Price behavior has been uneven, with momentum indicators frequently adjusting in response to external catalysts. A detailed evaluation of technical components—like support and resistance thresholds, volume patterns, and trend direction—offers a valuable perspective on how these companies are adapting to a complex market environment.

    Wallbox N.V (WBX)

    Wallbox N.V (NYSE: WBX)’s stock price has plunged by 3.86%relation to the previous closing price of $2.59. Nevertheless, the company has seen a 5.49% surge in its stock price over the last five trading sessions, with a -22.48% decline in the past month and a -8.19% plunge in the past quarter. The volatility ratio for the week is 4.39%, and the volatility levels for the past 30 days are at 6.91% for WBX. The simple moving average for the past 20 days is -4.90% for WBX’s stock, with a -36.42% simple moving average for the past 200 days.

    WBX Trading at -7.44% from the 50-Day Moving Average

    After a stumble in the market that brought WBX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with 66.37% of loss for the given period. Volatility was left at 6.91%, however, over the last 30 days, the volatility rate increased by 4.39%.

    ClearOne Inc (CLRO)

    ClearOne Inc (NASDAQ: CLRO) has experienced a decline in its stock price by -2.22% compared to its previous closing price of $4.05. However, the company has seen a fall of -8.88% in its stock price over the last five trading days, with a -16.19% drop in the past month and a -26.22% drop in the past quarter. The volatility ratio for the week is 8.39%, and the volatility levels for the past 30 days are 9.24% for CLRO. The simple moving average for the past 20 days is -11.41% for CLRO’s stock, with a -29.68% simple moving average for the past 200 days.

    CLRO Trading at -30.08% from the 50-Day Moving Average

    After a stumble in the market that brought CLRO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with 74.32% of loss for the given period. Volatility was left at 9.24%; however, over the last 30 days, the volatility rate increased by 8.39%.

    Hillcrest Energy Technologies Ltd. (HLRTF)

    Hillcrest Energy Technologies Ltd. (HLRTF) is approaching a critical phase in its development as it prepares to transition from prototype validation to real-world demonstrations. This stage is often considered a key inflection point for early-stage companies. Successful execution could significantly impact both adoption and investor perception.

    Market Momentum

    On March 24, the stock closed at $0.1110, down 2.63%, with trading volume of just 140 shares. The extremely low volume indicates limited market engagement despite ongoing developments. The company’s valuation remains in the nano-cap range.

    Strategic Expansion

    Hillcrest continues to engage with potential customers and partners ahead of its demonstration timeline. These interactions are essential for building commercial relationships. They also help validate market demand for its technology.

    Product Focus

    The PCS1000 inverter remains on track for demonstrations in June 2026 in Vancouver and Germany. It is designed to deliver over 99% efficiency while reducing electromagnetic interference. Its modular and scalable design makes it suitable for grid and energy storage applications.

    Sector Outlook

    Demonstration readiness is a major milestone in the energy sector. Technologies that prove performance in real-world settings are more likely to gain adoption. Hillcrest’s progress toward this stage is a positive signal.

  • Market Movers: What changed for these 37 stocks while you were sleeping

    Market Movers: What changed for these 37 stocks while you were sleeping

    Immutep Limited (NASDAQ: IMMP) shares are trading down -26.19% at $4.2 at the time of writing after reporting that its Chinese partner, EOC Pharma will begin a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China. Company’s 52-week ranged between $0.53 to $3.10. Analysts have a consensus price target of $7.75.
    SELLAS Life Sciences Group Inc. (SLS) stock plunged -24.18% to $13.39 in the pre-market trading. The most recent rating by Oppenheimer, on November 01, 2018, is an Outperform.
    Veru Inc. (VERU) tumbled over -11.89% at $5.26 in pre-market trading today. The firm recently declared that it has exclusively licensed phase 3 clinical stage targeted therapy for endocrine resistant metastatic breast cancer.
    Before the trading started on December 11, 2020, Professional Diversity Network Inc. (IPDN) is down -25.0% to reach $1.53. It has been trading in a 52-week range of $0.76 to $3.98.
    Neos Therapeutics Inc. (NEOS), a Drug Manufacturers – Specialty & Generic company, dropped about -16.36% at $0.6832 in pre-market trading Friday after announcing definitive merger agreement with Aytu BioScience, pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.
    Callon Petroleum Company (CPE) is down more than -0.53% at $15.0 in pre-market hours Friday December 11, 2020. The stock had jumped over 7.71% to $15.08 in the last trading session.
    C3.ai Inc. (AI) stock moved down -5.38 percent to $123.0 in the pre-market trading. The company lately declared the pricing of its initial public offering of 15,500,000 shares of its Class A common stock at a price of $42.00 per share.
    Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) shares are trading up 2.21% at $1.85 at the time of writing. Company’s 52-week ranged between $1.00 to $6.90. Analysts have a consensus price target of $14.
    Regulus Therapeutics Inc. (RGLS) stock plunged -9.92% to $1.09 in the pre-market trading. The healthcare company revealed closing of $19.4 million private placement of equity. The most recent rating by B. Riley FBR Inc., on March 28, 2018, is a Neutral.
    Range Resources Corporation (RRC) stock plunged -4.79% to $7.35 in the pre-market trading. The most recent rating by Stephens, on November 16, 2020, is an Overweight.
    Zedge Inc. (AMEX: ZDGE) shares are trading up 23.7% at $6.68 at the time of writing after reporting first fiscal quarter revenue growth of 85% and record overall quarterly financial results. Company’s 52-week ranged between $0.66 to $4.70. Analysts have a consensus price target of $3.
    Hennessy Capital Acquisition Corp. IV (HCAC), a Shell Companies company, dropped about -5.82% at $20.72 in pre-market trading Friday.
    Editas Medicine Inc. (EDIT) grew over 0.84% at $67.4 in pre-market trading today. The company recently publicized submission of IND application for EDIT-301 with the FDA.
    Greenwich LifeSciences Inc. (GLSI) is down more than -9.3% at $65.5 in pre-market hours Friday December 11, 2020 following the today’s announcement of poster presentation on its GP2 phase III clinical trial design for recurring breast cancer. The stock had jumped over 26.48% to $72.22 in the last trading session.
    Silver Spike Acquisition Corp. (SSPK) is down more than -2.78% at $14.0 in pre-market hours Friday December 11, 2020. The stock had jumped over 37.27% to $14.40 in the last trading session.
    Biocept Inc. (BIOC) stock plunged -3.07% to $5.68 in the pre-market trading after declaring results from a prospective study showing Target Selector™ was highly accurate in monitoring HER2 alterations in patients with metastatic breast cancer. The most recent rating by Chardan Capital Markets, on November 14, 2017, is a Buy.
    W&T Offshore Inc. (NYSE: WTI) shares are trading down -6.02% at $2.5 at the time of writing following the firm provided an operational update regarding fourth quarter 2020 production. Company’s 52-week ranged between $1.07 to $6.10.
    Before the trading started on December 11, 2020, Platinum Group Metals Ltd. (PLG) is up 1.93% to reach $5.27. It has been trading in a 52-week range of $0.86 to $5.20.
    Aytu BioScience Inc. (AYTU), a Biotechnology company, dropped about -24.72% at $6.12 in pre-market trading Friday after the company and Neos Therapeutics declared definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.
    Torchlight Energy Resources Inc. (TRCH) stock soared 13.78% to $0.7226 in the pre-market trading. The most recent rating by ROTH Capital, on March 13, 2020, is a Neutral.
    Before the trading started on December 11, 2020, Energy Fuels Inc. (UUUU) is up 1.64% to reach $3.1 following the announcement from the company that that its President and CEO Mark S. Chalmers will be presenting live at the 13th Annual LD Micro Main Event investor conference on Monday, December 14, 2020 at 11:40 AM (EST). It has been trading in a 52-week range of $0.78 to $2.99.
    Ashford Hospitality Trust Inc. (NYSE: AHT) shares are trading up 8.04% at $4.3 at the time of writing. Company’s 52-week ranged between $1.27 to $29.44.
    ClearOne Inc. (CLRO) stock plunged -7.2% to $2.45 in the pre-market trading after declaring that it has appointed Chromasound PLC, based in Budapest, Hungary, as its newest distribution partner. The most recent rating by Singular Research, on August 16, 2018, is a Buy – long-term.
    ReWalk Robotics Ltd. (NASDAQ: RWLK) shares are trading up 3.7% at $1.4 at the time of writing after revealing a contract with a German private health insurance company to allow all eligible beneficiaries with spinal cord injury (SCIs) to apply for the procurement of a ReWalk 6.0 exoskeleton system. Company’s 52-week ranged between $0.41 to $2.71. Analysts have a consensus price target of $1.50.
    Progenity Inc. (PROG) grew over 9.32% at $4.34 in pre-market trading today. The firm recently reported closing of the convertible senior notes offering and partial exercise of the Initial purchaser’s option to purchase additional notes.
    Boxlight Corporation (BOXL) is down more than -7.69% at $1.8 in pre-market hours Friday December 11, 2020. The stock had jumped over 17.47% to $1.95 in the last trading session.
    Lemonade Inc. (LMND), a Insurance – Property & Casualty company, rose about 0.7% at $100.4 in pre-market trading Friday. The company recently declared that residents of France can now get renters insurance instantly, anytime, and from any device – as well as file claims and get paid in seconds through the Lemonade app.
    ObsEva SA (OBSV) lost over -2.54% at $2.3 in pre-market trading Friday December 11, 2020 after announcing topline 52-week PRIMROSE 1 and 76-week PRIMROSE 2 results of Yselty, in development for the treatment of women with heavy menstrual bleeding due to uterine fibroids.
    Amplify Energy Corp. (AMPY) is down more than -27.33% at $1.09 in pre-market hours Friday December 11, 2020 following the commencement of an underwritten public offering of 8,548,485 shares of its common stock by certain of its stockholders which are affiliates of Fir Tree Capital Management L.P. The stock had jumped over 11.94% to $1.50 in the last trading session.
    Before the trading started on December 11, 2020, Hoth Therapeutics Inc. (HOTH) is up 0.54% to reach $1.85 after the firm revealed that it has received approval to commence phase 1b clinical trial of BioLexa for the treatment of Atopic Dermatitis in humans. It has been trading in a 52-week range of $1.60 to $7.25.
    RMG Acquisition Corp. (RMG) grew over 6.6% at $22.29 in pre-market trading today after declaring stockholder meeting Date of December 28, 2020.
    Marathon Patent Group Inc. (MARA) is down more than -10.34% at $4.68 in pre-market hours Friday December 11, 2020. The company recently stated that it has entered into a contract with Bitmain to purchase 10,000 Antminer S-19j Pro ASIC Miners. The stock had jumped over 9.21% to $5.22 in the last trading session.
    Before the trading started on December 11, 2020, Inseego Corp. (INSG) is up 7.26% to reach $13.15. The firm today reported that the it is expanding its global footprint in Japan with the launch of its industry-leading 5G MiFi® M2000 mobile hotspot. It has been trading in a 52-week range of $3.91 to $15.25.
    Entera Bio Ltd. (ENTX) tumbled over -7.56% at $1.1 in pre-market trading today after revealing FDA approval of IND application for EB613 – an oral human Parathyroid Hormone (1-34) for the treatment of Osteoporosis.
    OncoCyte Corporation (OCX) stock moved up 3.23 percent to $2.24 in the pre-market trading. The firm recently reported that it will host a key opinion leader (KOL) call on the Company’s proprietary DetermaRx™ and DetermaIO™ molecular tests for cancer treatment selection on Tuesday, December 15, 2020 at 11:00am Eastern Time.
    ZK International Group Co. Ltd. (ZKIN) lost over -4.98% at $2.1 in pre-market trading Friday December 11, 2020 after declaring that it signed a letter of intent with Tuopeng Industrial, a prominent construction and real estate company.
    Before the trading started on December 11, 2020, Arbutus Biopharma Corporation (ABUS) is up 15.8% to reach $4.25. It has been trading in a 52-week range of $0.88 to $9.02 following the declaration of additional clinical data from an ongoing Phase 1a/1b clinical trial (AB-729-001) with AB-729, its proprietary GalNAc delivered RNAi compound.

  • Two Reasons Why ClearOne Inc [CLRO] is a Perfect Buy at Current Prices

    Two Reasons Why ClearOne Inc [CLRO] is a Perfect Buy at Current Prices

    ClearOne Inc [NASDAQ:CLRO] has over the last few days 0recovered most of the losses from late August and the better part September. From a technical analysis perspective, the stock is at a price level where it can go in any direction. Ideally, the best entry point for this stock would be any price level above $3.

    However, looking at it from a fundamentals perspective, its current price makes for a good entry price as well and has the potential for more gains.  There are a number of factors that likely to drive up bullish sentiment in this stock in the near-term. Some of them are as below:

    Insider buying

    One of the biggest buy signals in the stock markets is insider buying. It usually points to a situation whereby people who have a close relationship with a company have faith in its growth prospects.  A few days ago, ClearOne Inc announced that it had agreed with a group of institutional and accredited investors, Edward Bagley (It’s the largest shareholder), and its CEO Zeynep Hakimoglu for the purchase of 2,116,050 units of common stock at a price of $2.4925 per share.

    In most cases, insider participation leads to an increase in stock as the fundamentals behind such a move start to unveil. In the case of ClearOne, it makes the stock’s current price a perfect entry point, for investors with both short-term and long-term projections for the stock.

    It is also noteworthy that the company intends to use the proceeds of the sale to bolster its working capital. This means that in the near-term, the company is well-positioned to carry out its operations without the risk of running out of money. This is a critical factor that could see it gain in value going into the foreseeable future.

    A patent win

    Back in August, the company announced that the patent trial and appeal board of the U.S and the Trade Mark Office had ruled in its favor in a case against Shure. The company announced that the ruling significantly limited Shure’s 493 patent touching on beamforming microphone arrays.

    This is a technology that was pioneered by ClearOne. The company stated that it believed its products do not infringe on Shure’s patent claims. This win is a big deal and is likely to have a significant impact on the company’s revenues in the long run, and by extension, its stock value.  This further adds weight to this stock’s potential in the long run.

    About ClearOne Inc

    ClearOne Inc designs, makes, and sells networking solutions. It is based in Salt Lake City, Utah.

  • Market Sentiment Mixed but there are Winners

    Market Sentiment Mixed but there are Winners

    The markets are headed to a mixed start to the week. The S&P 500 and the Dow are both in the red with the NASDAQ up marginally. The subdued sentiment is a reflection of activity in the European markets. Stocks in Europe are in the red as data shows a resurgence in COVID-19 cases. Essentially, this means that the world, including the U.S, is yet to fully control the pandemic.

    For the markets, this means a prolonged period of uncertainty and economic weakness. The Federal Reserve has already announced that it was projecting that the COVID-19 would continue to have a negative impact on the economy in the foreseeable future. Investors are looking to a future where subdued economic activity could potentially lead to a correction.

    Nonetheless, the U.S economy continues to show resilience. Even without an economic stimulus package from the government, the U.S economy continues to show signs of recovery in September.  This is an indicator that the underlying fundamentals are strong and that a new stimulus package or a COVIDD-19 vaccine could reignite the economy.

    In this environment of cautious optimism, there are stocks that are outperforming the market by a huge margin. In today’s session, some of the stocks showing signs of a major upside when markets open are as below:

    Immutep Limited [NASDAQ: IMMP]

    Immutep Limited is one of the top performers this morning and is up by close to 20%. This follows the company’s announcement of an improvement in results from stage 1 of its phase 2 TACTI-002 study. The company’s CMO Dr Fredric Triebel stated that by combining efti and pembrolizumab had shown good progress in people with HNSCC and NSCLC. The progress also attracted positive comments from external players. Commenting on it, principal investigator Dr Martin Forster of the University College London Hospital stated the results they received were encouraging.

    ClearOne Inc [NASDAQ: CLRO]

    This is another top performer this morning and is up by over 10%. This comes days after the company announced that it had priced $5.3 million direct offerings as per NASDAQ rule. The company announced that it would use money from the placement as working capital and other corporate purposes.

    Pivotal Investment Corporation II [NYSE: PIC]

    Pivotal Investment Corporation is another top performer this morning and is up by over 20% pre-market. This follows the company’s announcement that it was merging with XL Fleet, a commercial vehicle electrification company for listing on the NYSE. It is an interesting merger given XL’s growing demand and growing revenues.